Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study

PaperCitations, authors & open-access status

A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 105 citations, 2006 year and bronze oa status.

105
Citations
2006
Year
bronze
OA Status

Related on ScholarIQ

Kiyohiro Oshima
Author
Annals of Oncology
Journal
Lymphoma Diagnosis and Treatment
Topic
Lymphoma Diagnosis and Treatment
Topic
Blood disorders and treatments
Topic
Neutropenia and Cancer Infections
Topic
470M+ articles · free account